Effects of p38 MAPK signaling pathway on apoptosis stimulated by olaquindox in human hepatoma G2 cells

ZHAO Wen-xia,ZHANG Chao-ming,TANG Shu-sheng,ZHANG Ting,SUN Yu,JIN Xi,XIAO Xi-long

DOI: https://doi.org/10.3969/j.issn.1004-616x.2012.01.003

2012-01-01

Abstract:OBJECTIVE:To investigate the effect of p38 MAPK signaling pathway on the apoptosis induced by olaquindox in human hepatoma G2(HepG2) cells.METHODS:The HepG2 cells were treated with different concentrations(0,200,400,800μg/ml) of olaquindox for 24 h or with 800 p,g/ml olaquindox for different time points (0,0.5,1,2,4,6,12,24 h).Then the expression of p38 and phosphorylation of p38(p-p38) were determined by Western blot.The HepG2 cells which were pretreated with different concentrations(0,10,20μmol/L) of SB203580 for 1 h were subsequently treated with 800μg/ml olaquindox for 24 h.The changes of apoptosis were analyzed by Annexin VFITC and propidium iodide(PI) staining.RESULTS:The expression of p-p38 increased gradually with the dose and time of olaquindox treatment.Moreover,compared with control group,the expression of p-p38 was observably apparent with the treatment of 800μg/ml olaquindox for 24 h(P<0.01).Compared with olaquindox control group (23.1%±3.59%),the apoptosis of olaquindox-treated HepG2 cells was enhanced by different concentrations(10,20μmol/L) of SB203580 with the apoptotic rate of 35.4%±2.83%and 40.2%±3.98%respectively(P<0.05). CONCLUSION:p38 MAPK signaling pathway was activated by olaquindox,which played a role in inhibiting apoptosis induced by olaquindox-treated HepG2 cells.